Lysosomotropic Agents

Lysosomotropic Agents is a class of weakly basic compounds that selectively accumulate within lysosomes due to their ability to diffuse across membranes in an unprotonated form and become trapped upon protonation in the acidic lysosomal lumen, thereby modulating lysosomal function and autophagic flux.

616

Publications

48.9K

Citations

2.6K

Authors

745

Institutions

Publications per year

2017–2026

89

Authors

2.6K

  1. RA
    Raymond A. Firestone

    Bristol-Myers Squibb (United States), United States

    9 publications · 710 citations

    9

    h-index

  2. UT
    Ulf T. Brunk

    Linköping University, Sweden

    8 publications · 1.3K citations

    8

    h-index

  3. PO
    Per O. Seglen

    Norwegian Cancer Society, Norway

    7 publications · 1.8K citations

    7

    h-index

  4. JŁ
    Jacek Łuczyński

    Wrocław University of Science and Technology, Poland

    7 publications · 152 citations

    7

    h-index

  5. PB
    Paul B. Gordon

    Norwegian Cancer Society, Norway

    5 publications · 1.6K citations

    5

    h-index

1–5 of 2.6K

Venues

  1. Journal of Virology

    JVI · 37 publications · 3.3K citations

    32

    h-index

  2. Journal of Biological Chemistry

    JBC · 39 publications · 3.6K citations

    28

    h-index

  3. PubMed

    Repository · 40 publications · 2.5K citations

    24

    h-index

  4. The Journal of Immunology

    JI · 21 publications · 2.1K citations

    20

    h-index

  5. The Journal of Cell Biology

    JCB · 19 publications · 5.2K citations

    19

    h-index

1–5